Roche Holding AG (RHHBY) Stock
OTCRHHBY has an Alpha Score of 50 out of 100 (weak), computed on Oct 26, 2026 from 3 of 4 sub-scores. 17 members of Congress disclosed 54 trades in RHHBY since 2014: 28 purchases and 26 sales, most recently Ritchie John Torres (sale, Jul 11, 2025). Its trailing P/E ratio is 25.8 and its net margin 22.6% (key statistics as of Oct 29, 2026).
What is RHHBY's Alpha Score?
How it works →Alpha Score of 50 reflects weak overall profile with moderate momentum, weak value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 26, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded Roche Holding AG (RHHBY)?
Most recent: Ritchie John Torres (sale, Jul 11, 2025); records start Apr 4, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Ritchie Torres D-NY · House | 2025-07-11 | sale | $1k – $15k |
| Bruce Westerman R-AR · House | 2025-04-21 | sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2025-04-09 | partial sale | $1k – $15k |
| Bruce Westerman R-AR · House | 2025-03-03 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2024-07-23 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2024-06-21 | partial sale | $1k – $15k |
| Dan Goldman D-NY · House | 2023-07-10 | sale | $50k – $100k |
| Josh Gottheimer D-NJ · House | 2023-05-16 | partial sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all RHHBY political trades →What are RHHBY's key statistics?
Key statistics as of Oct 29, 2026
How does RHHBY's valuation compare with the Healthcare sector?
| Metric | RHHBY | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 25.8 | 27.1 | 97 |
| Net margin | 22.63% | 5.48% | 139 |
| Return on equity | 37.12% | 6.84% | 158 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
RHHBY price chart
Powered by TradingViewWhat does Roche Holding AG do?
Roche Holding AG is a leading pharmaceutical and diagnostics company based in Basel, Switzerland. As a pioneer in personalized healthcare, Roche dedicates itself to improving patient outcomes through scientific innovation and collaboration. Its pharmaceutical division focuses on developing drugs for oncology, immunology, infectious diseases, ophthalmology, and neuroscience, playing an essential role in advancing treatment options in these critical areas. The diagnostics division complements this by providing comprehensive laboratory solutions and pioneering in-vitro testing products, facilitating early and accurate disease diagnosis. Roche's strategic emphasis on research and development has solidified its position as an industry leader, exerting significant influence across the global healthcare sector. Through sustained investments in innovative therapies and diagnostic tools, Roche continues to drive advancements that shape modern medicine, impacting millions worldwide.